• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对安非他酮在人肝脏中还原生物转化的更深入了解。

Deeper insight into the reducing biotransformation of bupropion in the human liver.

作者信息

Skarydova Lucie, Tomanova Radana, Havlikova Lucie, Stambergova Hana, Solich Petr, Wsol Vladimir

机构信息

Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Králové, Charles University in Prague.

出版信息

Drug Metab Pharmacokinet. 2014;29(2):177-84. doi: 10.2133/dmpk.dmpk-13-rg-051. Epub 2013 Oct 1.

DOI:10.2133/dmpk.dmpk-13-rg-051
PMID:24088726
Abstract

Bupropion is widely used as an antidepressant drug and also as a smoking cessation aid. In humans, this drug is extensively metabolized to form several metabolites. Oxidised hydroxybupropion and two reduced metabolites, threohydrobupropion and erythrohydrobupropion, are major metabolites. All of these metabolites are considered to be active. Although the oxidative metabolic pathway and the central role of CYP2B6 are known, the enzymes that participate in the reduction have not been identified to date. The aim of this study was to confirm the role of human liver subcellular fractions in the metabolism of bupropion and elucidate the contribution of particular carbonyl-reducing enzymes. An HPLC method for the determination of bupropion metabolites was utilised. Bupropion is reduced to threohydrobupropion and less to erythrohydrobupropion in human liver cytosol, microsomes and also mitochondria. Surprisingly, intrinsic clearance for formation of both metabolites is the highest in mitochondrial fraction. Moreover this study provides the first direct evidence that 11β-hydroxysteroid dehydrogenase 1, AKR1C1, AKR1C2, AKR1C3 and CBR1 participate in the reducing biotransformation of bupropion in vitro. The enzyme kinetics of all of these reductases was investigated and kinetic parameters were calculated.

摘要

安非他酮被广泛用作抗抑郁药物,也用作戒烟辅助药物。在人体内,这种药物会广泛代谢形成多种代谢产物。氧化羟基安非他酮以及两种还原代谢产物,即苏式羟基安非他酮和赤式羟基安非他酮,是主要的代谢产物。所有这些代谢产物都被认为具有活性。尽管氧化代谢途径以及细胞色素P450 2B6(CYP2B6)的核心作用已为人所知,但迄今为止,参与还原反应的酶尚未得到鉴定。本研究的目的是确认人肝脏亚细胞组分在安非他酮代谢中的作用,并阐明特定羰基还原酶的贡献。采用了一种高效液相色谱法(HPLC)来测定安非他酮的代谢产物。在人肝脏胞质溶胶、微粒体以及线粒体中,安非他酮被还原为苏式羟基安非他酮,还原为赤式羟基安非他酮的量较少。令人惊讶的是,两种代谢产物形成的内在清除率在线粒体组分中最高。此外,本研究首次直接证明11β - 羟基类固醇脱氢酶1、醛酮还原酶1C1(AKR1C1)、醛酮还原酶1C2(AKR1C2)、醛酮还原酶1C3(AKR1C3)和羰基还原酶1(CBR1)在体外参与安非他酮的还原生物转化。研究了所有这些还原酶的酶动力学,并计算了动力学参数。

相似文献

1
Deeper insight into the reducing biotransformation of bupropion in the human liver.对安非他酮在人肝脏中还原生物转化的更深入了解。
Drug Metab Pharmacokinet. 2014;29(2):177-84. doi: 10.2133/dmpk.dmpk-13-rg-051. Epub 2013 Oct 1.
2
Metabolism of bupropion by carbonyl reductases in liver and intestine.安非他酮在肝脏和肠道中通过羰基还原酶进行的代谢。
Drug Metab Dispos. 2015 Jul;43(7):1019-27. doi: 10.1124/dmd.115.063107. Epub 2015 Apr 22.
3
Carbonyl reduction of bupropion in human liver.安非他酮在人肝脏中的羰基还原反应。
Xenobiotica. 2012 Jun;42(6):550-61. doi: 10.3109/00498254.2011.643416. Epub 2012 Feb 20.
4
Development, validation and application of a comprehensive stereoselective LC/MS-MS assay for bupropion and oxidative, reductive, and glucuronide metabolites in human urine.人尿中安非他酮及其氧化、还原和葡糖醛酸代谢物的综合立体选择性液相色谱/质谱联用测定法的开发、验证及应用
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Aug 1;1027:239-53. doi: 10.1016/j.jchromb.2016.05.036. Epub 2016 May 24.
5
Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1.从丁丙诺啡形成赤型氢丁丙诺啡依赖于 11β-羟类固醇脱氢酶 1。
Drug Metab Dispos. 2013 Sep;41(9):1671-8. doi: 10.1124/dmd.113.052936. Epub 2013 Jun 26.
6
Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases.华法林的羰基还原:人华法林还原酶的鉴定和特性。
Biochem Pharmacol. 2016 Jun 1;109:83-90. doi: 10.1016/j.bcp.2016.03.025. Epub 2016 Apr 4.
7
Bupropion metabolism by human placenta.人胎盘对丁丙诺啡的代谢作用。
Biochem Pharmacol. 2010 Jun 1;79(11):1684-90. doi: 10.1016/j.bcp.2010.01.026. Epub 2010 Jan 28.
8
Comparison of In Vitro Stereoselective Metabolism of Bupropion in Human, Monkey, Rat, and Mouse Liver Microsomes.安非他酮在人、猴、大鼠和小鼠肝微粒体中的体外立体选择性代谢比较。
Eur J Drug Metab Pharmacokinet. 2019 Apr;44(2):261-274. doi: 10.1007/s13318-018-0516-4.
9
The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man.羰基还原酶在奥卡西平体外代谢中的作用。
Chem Biol Interact. 2014 Sep 5;220:241-7. doi: 10.1016/j.cbi.2014.07.005. Epub 2014 Jul 22.
10
Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4'-OH-bupropion in vitro.安非他酮在体外立体选择性代谢为羟基安非他酮、苏式羟基安非他酮、赤式羟基安非他酮和4'-羟基安非他酮。
Drug Metab Dispos. 2016 Oct;44(10):1709-19. doi: 10.1124/dmd.116.072363. Epub 2016 Aug 5.

引用本文的文献

1
Developed and Validated for the Estimation of Bupropion and Dextromethorphan in a Fixed Dose Combination of the Tablet.已开发并验证用于测定片剂固定剂量组合中的安非他酮和右美沙芬。
Turk J Pharm Sci. 2024 May 14;21(2):125-132. doi: 10.4274/tjps.galenos.2023.87522.
2
Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux.布鲁顿酪氨酸激酶抑制剂泽布替尼通过抑制蒽环类药物代谢和外排有效调节癌症耐药性。
Pharmaceutics. 2022 Sep 21;14(10):1994. doi: 10.3390/pharmaceutics14101994.
3
Stereoselective Metabolism of Bupropion to Active Metabolites in Cellular Fractions of Human Liver and Intestine.
人肝和肠细胞组分中布普品对映体选择性代谢为活性代谢物。
Drug Metab Dispos. 2023 Jan;51(1):54-66. doi: 10.1124/dmd.122.000867. Epub 2022 May 5.
4
Metabolic-Hydroxy and Carboxy Functionalization of Alkyl Moieties in Drug Molecules: Prediction of Structure Influence and Pharmacologic Activity.药物分子中烷基部分的代谢-羟基和羧基官能化:结构影响和药理活性预测。
Molecules. 2020 Apr 22;25(8):1937. doi: 10.3390/molecules25081937.
5
Transport of Bupropion and its Metabolites by the Model CHO and HEK293 Cell Lines.安非他酮及其代谢物在CHO和HEK293细胞系模型中的转运
Drug Metab Lett. 2019;13(1):25-36. doi: 10.2174/1872312813666181129101507.
6
Selective Inhibition of Human AKR1B10 by -Humulone, Adhumulone and Cohumulone Isolated from Extract.从啤酒花浸膏中分离得到的 -葎草酮、副葎草酮和合葎草酮对人 AKR1B10 的选择性抑制作用。
Molecules. 2018 Nov 21;23(11):3041. doi: 10.3390/molecules23113041.
7
Comparison of In Vitro Stereoselective Metabolism of Bupropion in Human, Monkey, Rat, and Mouse Liver Microsomes.安非他酮在人、猴、大鼠和小鼠肝微粒体中的体外立体选择性代谢比较。
Eur J Drug Metab Pharmacokinet. 2019 Apr;44(2):261-274. doi: 10.1007/s13318-018-0516-4.
8
The hop-derived compounds xanthohumol, isoxanthohumol and 8-prenylnaringenin are tight-binding inhibitors of human aldo-keto reductases 1B1 and 1B10.啤酒花衍生化合物黄腐酚、异黄腐酚和8-异戊烯基柚皮素是人类醛糖酮还原酶1B1和1B10的紧密结合抑制剂。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):607-614. doi: 10.1080/14756366.2018.1437728.
9
Pharmacokinetics and Pharmacogenomics of Bupropion in Three Different Formulations with Different Release Kinetics in Healthy Human Volunteers.三种不同释放动力学的安非他酮配方在健康人体志愿者中的药代动力学和药物基因组学研究。
AAPS J. 2017 Sep;19(5):1513-1522. doi: 10.1208/s12248-017-0102-8. Epub 2017 Jul 6.
10
Identification of non-reported bupropion metabolites in human plasma.人血浆中未报告的安非他酮代谢物的鉴定。
Biopharm Drug Dispos. 2016 Dec;37(9):550-560. doi: 10.1002/bdd.2046.